Back to Search
Start Over
Development of Stable Chimeric IL-15 for Trans-Presentation by the Antigen Presenting Cells.
- Source :
-
Frontiers in immunology [Front Immunol] 2021 Apr 19; Vol. 12, pp. 646159. Date of Electronic Publication: 2021 Apr 19 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- IL-15 is one of the important biologics considered for vaccine adjuvant and treatment of cancer. However, a short half-life and poor bioavailability limit its therapeutic potential. Herein, we have structured IL-15 into a chimeric protein to improve its half-life enabling greater bioavailability for longer periods. We have covalently linked IL-15 with IgG2 base to make the IL-15 a stable chimeric protein, which also increased its serum half-life by 40 fold. The dimeric structure of this kind of IgG based biologics has greater stability, resistance to proteolytic cleavage, and less frequent dosing schedule with minimum dosage for achieving the desired response compared to that of their monomeric forms. The structured chimeric IL-15 naturally forms a dimer, and retains its affinity for binding to its receptor, IL-15Rβ. Moreover, with the focused action of the structured chimeric IL-15, antigen-presenting cells (APC) would transpresent chimeric IL-15 along with antigen to the T cell, that will help the generation of quantitatively and qualitatively better antigen-specific memory T cells. In vitro and in vivo studies demonstrate the biological activity of chimeric IL-15 with respect to its ability to induce IL-15 signaling and modulating CD8 <superscript>+</superscript> T cell response in favor of memory generation. Thus, a longer half-life, dimeric nature, and anticipated focused transpresentation by APCs to the T cells will make chimeric IL-15 a super-agonist for memory CD8 <superscript>+</superscript> T cell responses.<br />Competing Interests: MP, NY and SD have ownership interest in patent filed for improved chimeric IL-15 [Indian patent number: E-2/2703/2017/MUM; App. Number: 201721010096 (published)].<br /> (Copyright © 2021 Patidar, Yadav and Dalai.)
- Subjects :
- Animals
CHO Cells
Cricetulus
Female
Genes, Immunoglobulin Heavy Chain
Humans
Immunoglobulin G chemistry
Interleukin-15 chemistry
Interleukin-15 genetics
Interleukin-15 metabolism
Interleukin-2 Receptor beta Subunit metabolism
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Protein Multimerization
Protein Stability
Antigen Presentation immunology
Antigen-Presenting Cells immunology
Interleukin-15 immunology
Recombinant Fusion Proteins immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 33953717
- Full Text :
- https://doi.org/10.3389/fimmu.2021.646159